MANNIN RESEARCH MOVES INTO JOHNSON & JOHNSON INNOVATION, JLABS @ TORONTO

Mannin Research is pleased to announce that it has been accepted into Johnson & Johnson Innovation, JLABS @ Toronto. JLABS @ Toronto is a 40,000 square-foot life science innovation center. The labs provide a flexible environment for start-up companies pursuing new technologies and research platforms to advance medical care. Through a “no strings attached” model, Johnson & Johnson Innovation does not take an equity stake in the companies occupying...

MANNIN RESEARCH EXECUTIVES TO ATTEND GLAUCOMA 360: NEW HORIZONS FORUM

Mannin Research Inc. will attend the 6th Annual New Horizons Forum at Glaucoma Research Foundation’s Glaucoma 360 conference. The New Horizons Forum, will take place February 3, 2017 at the Palace Hotel in San Francisco, California. This full day meeting brings together key opinion leaders of clinical care, glaucoma research, pharmaceutical and medical device enterprise, and start-ups. Launched by Glaucoma Research Foundation, the meeting is designed to bring the...

MANNIN RESEARCH INC. TO PARTICIPATE IN A WEBCAST ON INNOVATING FOR OPHTHALMIC DISEASES

Webcast, part of the Nature.Com BioPharma Dealmakers series, is scheduled for 10:00 am ET on October 20th.   Mannin Research Inc. will present in a webcast on Innovating for Ophthalmic Diseases on October 20th at 10AM ET. Dr. George Nikopoulos, CEO and President of Mannin Research Inc. will participate in a BioPharma Dealmakers webcast, sponsored in part by Mannin Research Inc., featuring three companies innovating in therapies for eye...